Imagine you are developing antibodies—drugs precisely aimed at a target, for example a viral protein or onco-marker. You test a series of antibodies and find that some work, while others do not.

As Meta unveils its powerful on-device reasoner, a wider industry trend emerges where small, specialized models are solving enterprise challenges around cost, privacy, and control.

DeepSeek-R1 uses reinforcement learning to teach reasoning, showing potential for AI to develop intelligence without human ...

New glasses with a built-in display bring Meta's vision of the augmented reality future into focus. The popular Ray-Bans also ...

The AI models, which are built on massive datasets and can be adapted to multiple tasks, have become a part of medtech ...

Recurrent Neural Networks (RNNs) are AI models designed to process sequential data, capable of sequentially handling words and temporarily storing previously processed information in short-term memory ...

In a user interface about-turn that has some resemblance to that of Volkswagen, Mercedes-Benz will start to integrate more ...

The UC Berkeley Possibility Lab and California Forward (CA FWD) announced today the release of the Energy Project Benefits Agreement Database , a new online tool allowing the public to search examples ...

Embrace city science as a vital partner in architecture, merging creativity with data to build resilient and equitable urban ...

This technology could be used to promote timely lifestyle changes or to design health policies, but experts warn of its ...

The core of this patent lies in the proposed data analysis method based on a large model. The method first receives a data analysis request and parses the request to obtain key information. If key ...

Returning to the Jogger specifically, a facelifted model remains on schedule for launch in 2026 with the successor set for a ...